According to Verve Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.17. In 2022 the company made an earnings per share (EPS) of -$2.92 a decrease over its 2021 EPS that were of -$2.53.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$3.17 | 8.56% |
2022 | -$2.92 | 15.54% |
2021 | -$2.53 | 61.32% |
2020 | -$1.57 |